Orion Bionetworks MS Project Plumbs Big Data To Revitalize CNS Drug Development
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
A diverse group of public and private institutions has launched a precompetitive data sharing and predictive modeling effort called Orion Bionetworks, using computational biology to sift through imaging, genetic and biologic data from thousands of patients to identify the molecular underpinnings of multiple sclerosis and accelerate the pursuit of cures. Johnson & Johnson provided $5.4 million to fund the project.